IBOGF 0.01 Universal Ibogaine Inc.
| Range: | 0.0013-0.055 | Vol Avg: | 8560 | Last Div: | 0 | Changes: | 0 |
| Beta: | 5.16 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Tue Mar 01 2022 | Empoloyees: | |||
| CUSIP: | CIK: | ISIN: | CA91360F1099 | Country: | CA | ||
| CEO: | Mr. Nicholas Peter Karos | Website: | https://universalibogaine.com | ||||
Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. It undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. The company is headquartered in Calgary, Canada.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow